ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Pass Below 200-Day Moving Average – What’s Next?

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBGet Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $59.59 and traded as low as $55.06. ProShares Ultra Nasdaq Biotechnology shares last traded at $55.17, with a volume of 9,601 shares trading hands.

ProShares Ultra Nasdaq Biotechnology Trading Down 0.3 %

The firm has a 50-day moving average of $53.40 and a 200 day moving average of $59.59.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The business also recently declared a dividend, which was paid on Tuesday, December 31st. Investors of record on Monday, December 23rd were given a dividend of $0.3964 per share. The ex-dividend date was Monday, December 23rd. This is a boost from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Tower Research Capital LLC TRC boosted its position in ProShares Ultra Nasdaq Biotechnology by 31.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,326 shares of the exchange traded fund’s stock valued at $270,000 after purchasing an additional 1,266 shares during the last quarter. Crowley Wealth Management Inc. acquired a new stake in shares of ProShares Ultra Nasdaq Biotechnology in the fourth quarter valued at approximately $51,000. Finally, Jane Street Group LLC lifted its position in shares of ProShares Ultra Nasdaq Biotechnology by 8.4% in the third quarter. Jane Street Group LLC now owns 4,803 shares of the exchange traded fund’s stock valued at $306,000 after buying an additional 374 shares during the last quarter.

ProShares Ultra Nasdaq Biotechnology Company Profile

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.

Featured Articles

Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.